KR20110139256A - Ｓｐａｒｃ 혈관형성 영역과 사용방법 - Google Patents

Ｓｐａｒｃ 혈관형성 영역과 사용방법 Download PDF

Info

Publication number
KR20110139256A
KR20110139256A KR1020117023819A KR20117023819A KR20110139256A KR 20110139256 A KR20110139256 A KR 20110139256A KR 1020117023819 A KR1020117023819 A KR 1020117023819A KR 20117023819 A KR20117023819 A KR 20117023819A KR 20110139256 A KR20110139256 A KR 20110139256A
Authority
KR
South Korea
Prior art keywords
tumors
polypeptide
sparc
seq
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020117023819A
Other languages
English (en)
Korean (ko)
Inventor
부옹 트리에우
다니엘 크나우어
네일 데자이
Original Assignee
아브락시스 바이오사이언스, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아브락시스 바이오사이언스, 엘엘씨 filed Critical 아브락시스 바이오사이언스, 엘엘씨
Publication of KR20110139256A publication Critical patent/KR20110139256A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
KR1020117023819A 2009-03-11 2010-03-11 Ｓｐａｒｃ 혈관형성 영역과 사용방법 Ceased KR20110139256A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15932209P 2009-03-11 2009-03-11
US61/159,322 2009-03-11

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020137008481A Division KR20130043242A (ko) 2009-03-11 2010-03-11 Ｓｐａｒｃ 혈관형성 영역과 사용방법

Publications (1)

Publication Number Publication Date
KR20110139256A true KR20110139256A (ko) 2011-12-28

Family

ID=42729116

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020117023819A Ceased KR20110139256A (ko) 2009-03-11 2010-03-11 Ｓｐａｒｃ 혈관형성 영역과 사용방법
KR1020137008481A Ceased KR20130043242A (ko) 2009-03-11 2010-03-11 Ｓｐａｒｃ 혈관형성 영역과 사용방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020137008481A Ceased KR20130043242A (ko) 2009-03-11 2010-03-11 Ｓｐａｒｃ 혈관형성 영역과 사용방법

Country Status (13)

Country Link
US (2) US20120087910A1 (enExample)
EP (1) EP2405932A4 (enExample)
JP (1) JP2012520081A (enExample)
KR (2) KR20110139256A (enExample)
CN (2) CN102482334A (enExample)
AU (1) AU2010224031B2 (enExample)
BR (1) BRPI1009457A2 (enExample)
CA (1) CA2755109A1 (enExample)
IL (2) IL215089A0 (enExample)
MX (1) MX2011009478A (enExample)
NZ (1) NZ595528A (enExample)
WO (1) WO2010105097A2 (enExample)
ZA (1) ZA201107415B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2544704A4 (en) * 2010-03-11 2013-08-28 Abraxis Bioscience Llc SPARC ANGIOGENIC DOMAIN AND METHODS OF USE
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
CN120361186A (zh) * 2025-04-15 2025-07-25 北京大学口腔医学院 一种促进血管生成和组织再生的药物组合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001266787A1 (en) * 2000-06-07 2002-01-08 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
EP1869077A2 (en) * 2005-02-18 2007-12-26 Abraxis BioScience, Inc. Q3 sparc deletion mutant and uses thereof
AU2007264361B2 (en) * 2006-06-26 2013-07-18 The University Of British Columbia Secreted Protein Acidic and Rich in Cysteine (SPARC) as chemotherapeutic sensitizers
CA2683973A1 (en) * 2007-04-13 2008-10-23 Abraxis Bioscience, Inc. Sparc and methods of use thereof

Also Published As

Publication number Publication date
IL215089A0 (en) 2011-11-30
CN102482334A (zh) 2012-05-30
AU2010224031B2 (en) 2013-05-02
BRPI1009457A2 (pt) 2016-03-01
WO2010105097A2 (en) 2010-09-16
EP2405932A4 (en) 2012-08-22
NZ595528A (en) 2013-10-25
CN103724417A (zh) 2014-04-16
CA2755109A1 (en) 2010-09-16
IL228795A0 (en) 2013-12-31
WO2010105097A3 (en) 2010-11-04
JP2012520081A (ja) 2012-09-06
EP2405932A2 (en) 2012-01-18
US20120087910A1 (en) 2012-04-12
US20140094416A1 (en) 2014-04-03
AU2010224031A1 (en) 2011-10-06
WO2010105097A8 (en) 2011-05-26
MX2011009478A (es) 2011-11-18
AU2010224031A2 (en) 2011-10-20
ZA201107415B (en) 2012-06-27
KR20130043242A (ko) 2013-04-29

Similar Documents

Publication Publication Date Title
CN102245632B (zh) Muc-1胞质结构域肽作为癌症的抑制剂
US20140094416A1 (en) Sparc angiogenic domain and methods of use
JP6825181B2 (ja) 膵炎を治療するための薬剤の製造におけるｉｌ−２２二量体の使用
JP2014144014A (ja) 化学療法増感剤としてのシステインに富む酸性分泌タンパク質（ｓｐａｒｃ）
CA2945812A1 (en) Trail receptor agonists for treatment of fibrotic diseases
US11142561B2 (en) B1SP fusion protein therapeutics, methods, and uses
KR20130010477A (ko) Ｓｐａｒｃ 혈관형성 영역과 사용방법
HK1194403A (en) Sparc angiogenic domain and methods of use
HK1167664A (en) Sparc angiogenic domain and methods of use
AU2013211470A1 (en) Sparc angiogenic domain and methods of use

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20111010

Patent event code: PA01051R01D

Comment text: International Patent Application

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20111012

Comment text: Request for Examination of Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20121203

Patent event code: PE09021S01D

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20130402

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20130809

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20121203

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I